INGREZZA® (valbenazine) Capsules
搜索文档
Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden
Prnewswire· 2025-09-23 12:30
药物临床数据分析 - KINECT-PRO™分析是首个且唯一报告迟发性运动障碍症状缓解及相关患者报告结局改善的分析 [1] - 事后分析显示第24周时出现显著的症状缓解率 且时间早于既往研究报告 [1]
